BARCLAYS PLC

Position in OBIO — Orchestra BioMed Holdings, Inc.

CIK 312069 LONDON, X0

Position in OBIO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$252,203

-$140,041 QoQ

Shares Held

59,342

-37.2% QoQ

Ownership

0.099%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $1,494,072,071 across 362 Biotechnology names. OBIO ranks #202 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	663,263	$296,173,457
2	REGN	Regeneron Pharmaceuticals, Inc.	313,093	$241,908,173
3	ALNY	Alnylam Pharmaceuticals, Inc.	220,623	$72,997,531
4	MRNA	Moderna, Inc.	932,269	$47,359,264
5	INSM	INSMED Inc	275,731	$45,087,531
6	ROIV	Roivant Sciences Ltd.	1,415,848	$39,218,988
7	RVMD	Revolution Medicines, Inc.	383,179	$37,264,156
8	TERN	Terns Pharmaceuticals, Inc.	669,601	$35,301,364

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$252,203	59,342	-37.2%	Shares	Defined	2026-05-15
2025-12-31	$392,244	94,517	+9451600.0%	Shares	Sole	2026-02-13
2025-09-30	$2	1	-99.9%	Shares	Sole	2026-03-31
2025-06-30	$2,342	874	-96.6%	Shares	Sole	2026-02-27
2025-03-31	$109,606	25,609	-32.2%	Shares	Sole	2026-03-17
2024-12-31	$151,144	37,786	+18.9%	Shares	Sole	2026-03-19
2024-09-30	$163,374	31,785	+281.3%	Shares	Sole	2026-03-31
2024-06-30	$67,946	8,337	-20.2%	Shares	Sole	2026-03-23
2024-03-31	$55,060	10,448	-48.1%	Shares	Sole	2026-03-24
2023-12-31	$183,887	20,141	+538.8%	Shares	Sole	2026-03-24
2023-09-30	$27,494	3,153	+0.9%	Shares	Sole	2026-03-26
2023-06-30	$21,875	3,125	-55.1%	Shares	Sole	2026-03-27
2023-03-31	$136,089	6,954	—	Shares	Sole	2026-03-30
No filing history on record for this holder in this stock.